Found 18 matching trials
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC PHASE2 Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma PHASE2 Purpose: This phase II clinical trial evaluates whether a combination of li...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC PHASE2 The purpose of the study is to observe the effect of TACE/HAIC combined wit...
Show More Location
Third Affiliated Hospital, Sun Yat-Sen University
Learn More & Join Trial
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery PHASE2 This study is a prospective, randomized, controlled, open, phase II, multic...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC N/A China is a high-risk area of Hepatocellular Carcinoma (HCC). Although Chine...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC PHASE2 This trial is designed to explore the efficacy and safety of interventional...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial NA Hepatocellular carcinoma (HCC) is one of the most commonly malignant tumors...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT PHASE3 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial